Key result
Warfarin therapy in 23 patients with malignant glial tumors and thromboembolic complications resulted in 1 recurrent pulmonary embolism and no radiographic evidence of intratumoral hemorrhage.
Why the study?
Does anticoagulant therapy safely and effectively treat thromboembolic complications in patients with primary malignant brain tumors?
Observational (n=23)
Does anticoagulant therapy safely and effectively treat thromboembolic complications in patients with primary malignant brain tumors?
Oral anticoagulant therapy appears to be a safe and effective means of treating thromboembolic complications in patients with residual malignant glial tumors without causing significant intratumoral hemorrhage.
Answers are grounded in this paper and cite their sources.
Anticoagulation showed low recurrence in this small brain tumor series; hypothesis-generating and requires prospective trials before practice change.
Twenty-three patients with malignant glial neoplasms were treated with anticoagulant therapy for thromboembolic complications. Fifteen patients had deep vein thrombosis alone, and 8 patients had both deep vein thrombosis and pulmonary embolism. Serum prothrombin times were maintained at 1.25 times control for an average of 5.8 months per patient, for a total patient exposure to warfarin therapy of 132 patient-months (11 patient-years). Only 1 patient suffered a recurrent pulmonary embolism, and this occurred during an episode of gastrointestinal bleeding, when anticoagulant therapy had to be discontinued prematurely. All patients were followed with serial computed tomographic or magnetic resonance imaging scans, and no patient showed radiographic evidence of intratumoral hemorrhage either during or after warfarin therapy. One patient, who died from a large recurrent glioblastoma, was found at autopsy to have scattered foci of intratumoral hemorrhage. This series, together with a review of the available literature, suggests that oral anticoagulant therapy is both a safe and effective means of treating thromboembolic complications in patients with residual malignant glial tumors.
No takes yet. Share an insight, caveat, or question.
Altschuler et al. (1990) conducted an observational in Malignant glial neoplasms with thromboembolic complications (n=23). Anticoagulant therapy (warfarin) was evaluated on Recurrent pulmonary embolism and intratumoral hemorrhage. Warfarin therapy in 23 patients with malignant glial tumors and thromboembolic complications resulted in 1 recurrent pulmonary embolism and no radiographic evidence of intratumoral hemorrhage.
Synapse has enriched 10 related papers. Consider them for comparative context: